ALLE vs CHRS · P/E 21, rev $2.19B vs rev $26.6M
Allegion PLC (ALLE) versus Coherus BioSciences Inc (CHRS) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. CHRS currently screens at market cap $223.7M.
Not investment advice. Open the ALLE and CHRS stock pages for the full models.
Not investment advice.